A food safety emergency that began quietly in January 2026 has grown into one of the most widespread Salmonella outbreaks in recent memory. The CDC's alert update released June 5 shows that contaminated products may still be in homes across the United States, while new cases continue to be reported.
The CDC confirmed that the outbreak linked to moringa products now includes 119 cases across 36 states, with 32 hospitalizations and no deaths. This update adds 22 new cases and 6 new hospitalizations, along with four additional states affected since the last report.
A second Salmonella outbreak tied to different moringa products, sold under the Mogo brand, has also been identified. It includes 18 cases across 14 states and 7 hospitalizations.
Together, the two outbreaks account for 137 confirmed Salmonella infections linked to moringa leaf products. Health officials say the true number is likely higher because many people with Salmonella do not get tested or seek medical care.
The products at the center of the expanded outbreak are dietary supplements marketed as "green superfood" products and made with imported moringa leaf powder.
On June 2, 2026, Total Nutrition Inc. of Deer Park, New York, expanded its recall to include an additional lot of TNVitamins and Doctor's Pride-brand moringa capsules. Earlier recalls involved Live it Up Super Greens powder (all lots beginning with the letter "A"; all stick packs with expiration dates 08/2026 to 01/2028), Why Not Natural Pure Organic Moringa capsules, and Superfoods Inc. products.
These products were sold nationwide, including in California, New York, Texas, Florida, Illinois, and Pennsylvania, the five most populous states in the country, through both online retailers and physical supplement stores.
The Demographic Geography of the Outbreak
Moringa is not a fringe supplement. It is one of the most heavily marketed "superfood" products in recent years, promoted as a nutritional powerhouse with claimed benefits for energy, blood sugar control, inflammation, and immune support.
Its marketing is aimed at health-conscious consumers who are also the biggest buyers of dietary supplements, including urban, educated, middle- to upper-income adults who regularly purchase green powders, capsules, and other wellness products.
In New York City, Los Angeles, Houston, Dallas, and Chicago, the largest metropolitan markets for supplement sales, moringa products have a large consumer base. Many customers may have bought these products within the past six to twelve months and may not yet be aware of the recall or have taken action in response.
That is the CDC's core concern in its June 5 alert: "recalled products may still be in homes." The shelf life of these products means the risk may continue for some time. Many capsule products expire in 2027 and 2028, and powders have similar long expiration timelines.
A container of contaminated moringa capsules purchased in the fall of 2025 and left partially used in a kitchen cabinet in Brooklyn or Brentwood could still pose an exposure risk each time it is opened. The outbreak strain, Salmonella Typhimurium and Salmonella Newport, was confirmed in 59 of 67 people interviewed, or 88 percent, who reported eating a product containing moringa leaf powder. Health investigators say this pattern strongly links the illness to the product.
The Science of Why Imported Herbal Supplements Carry Salmonella Risk
The moringa Salmonella outbreak is not a case of isolated manufacturing failure. It highlights a broader weakness in the global herbal supplement supply chain that food safety researchers have warned about for years. Dried plant products grown in warm, humid regions have some of the highest known rates of contamination with Salmonella and other foodborne bacteria.
Moringa (Moringa oleifera) is primarily grown in South Asia, sub-Saharan Africa, and Latin America. In these regions, factors such as water quality, animal waste in farming areas, and drying practices after harvest can all increase the risk of contamination before the product is ever processed or packaged.
Unlike fresh produce, which is subject to certain safety rules before being sold, dried herbal supplements fall into a more loosely regulated category. Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), companies are responsible for ensuring their products are safe. However, they are not required to conduct pre-market safety testing or obtain FDA approval before selling supplements, including routine testing for harmful bacteria.
In this case, contaminated moringa powder appears to have entered the supply chain through a shared ingredient supplier used by multiple brands. The contamination was only identified after a detailed investigation by the FDA and CDC, following reports of illness and hospitalizations.
What You Need to Check in Your Home Right Now
The CDC's guidance is clear and urgent: consumers should check their homes for any of the recalled products and either throw them away immediately or return them to the place of purchase.
The recalled items include all Live it Up Super Greens supplement powder products (original and wild berry), all lots beginning with the letter "A," and all stick-pack products with expiration dates from 08/2026 to 01/2028. Also included are Why Not Natural Pure Organic Moringa Green Superfood capsules, lot A25G051, expiration 07/2028.
Other recalled products include TNVitamins Ultra Potent Complete Green Superfood Moringa 10,000 mg capsules (lots 2507199, expiration 09/2027; 2512-304, expiration 02/2028; and 2793, expiration 02/2028), along with Doctor's Pride Complete Green Superfood capsules from the same lots. The list also includes the Mogo brand Pure Moringa Oleifera Capsules covered under the May 25, 2026, recall.
For current complete recall listings and lot numbers, visit the FDA's outbreak investigation page. If you have consumed any of these products and developed fever, diarrhea, and stomach cramps within 6 hours to 6 days, contact your healthcare provider. People at highest risk for severe illness are children under 5, adults 65 and older, and immunocompromised individuals.
